v3.25.4
UNAUDITED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' (DEFICIT) EQUITY - USD ($)
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total Shareholder Deficit [Member]
Balance – July 31, 2024 at Jul. 22, 2024
Beginning balance, shares at Jul. 22, 2024 [1]      
Net loss
Balance – October 31, 2024 at Jul. 31, 2024
Ending balance, shares at Jul. 31, 2024 [1]      
Balance – July 31, 2024 at Jul. 22, 2024
Beginning balance, shares at Jul. 22, 2024 [1]      
Ordinary shares issued to underwriter $ 20 4,328  
Ordinary shares issued to underwriter, shares 200,000      
Balance – October 31, 2024 at Jan. 31, 2025 [1] $ 307 29,041 (42,564) (13,216)
Ending balance, shares at Jan. 31, 2025 [1] 3,075,000      
Balance – July 31, 2024 at Jul. 31, 2024
Beginning balance, shares at Jul. 31, 2024 [1]      
Founder shares issued to the Sponsor [1] $ 287 24,713 25,000
Founder shares issued to the Sponsor, shares [1] 2,875,000      
Ordinary shares issued to underwriter $ 20 4,328 4,348
Ordinary shares issued to underwriter, shares [1] 200,000      
Net loss (42,564) (42,564)
Balance – October 31, 2024 at Oct. 31, 2024 $ 307 29,041 (42,564) (13,216)
Ending balance, shares at Oct. 31, 2024 [1] 3,075,000      
Balance – July 31, 2024 at Jan. 31, 2025 [1] $ 307 29,041 (42,564) (13,216)
Beginning balance, shares at Jan. 31, 2025 [1] 3,075,000      
Net loss (19,553) (19,553)
Balance – October 31, 2024 at Apr. 30, 2025 [1] $ 307 29,041 (62,117) (32,769)
Ending balance, shares at Apr. 30, 2025 [1] 3,075,000      
Issuance of Private Placement Units $ 30 2,987,470 2,987,500
Issuance of Private Placement Units, shares [1] 298,750      
Issuance of Public Rights net of issuance costs 1,337,837 1,337,837
Issuance of representative shares 247,556 247,556
Remeasurement of carrying value to redemption value (4,504,618) (4,504,618)
Net loss 307,410 307,410
Balance – October 31, 2024 at Jul. 31, 2025 $ 337 97,286 245,293 342,916
Ending balance, shares at Jul. 31, 2025 [1] 3,373,750      
Remeasurement of carrying value to redemption value (888,798) (888,798)
Accretion of additional paid-in capital to accumulated deficit 791,512 (791,512)
Net loss 514,636 514,636
Balance – October 31, 2024 at Oct. 31, 2025 $ 337 $ (31,583) $ (31,246)
Ending balance, shares at Oct. 31, 2025 [1] 3,373,750      
[1] Includes an aggregate of up to 375,000 ordinary shares subject to forfeiture if the over-allotment is not exercised in full or in part by the underwriters (see Note 5).